This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1984 Dec;101(6):878.

doi: 10.7326/0003-4819-101-6-878_1.

Sulfasalazine and ankylosing spondylitis

B Amor, A Kahan, M Dougados, F Delrieu

PMID: 6149718
DOI: 10.7326/0003-4819-101-6-878_1

Sulfasalazine and ankylosing spondylitis

B Amor et al. Ann Intern Med. 1984 Dec.

. 1984 Dec;101(6):878.

doi: 10.7326/0003-4819-101-6-878_1.

Authors

B Amor, A Kahan, M Dougados, F Delrieu

PMID: 6149718
DOI: 10.7326/0003-4819-101-6-878_1

No abstract available

PubMed Disclaimer

Similar articles

[Sulfasalazine in the treatment of ankylosing spondylitis].
Krajnc I. Krajnc I. Lijec Vjesn. 1990 May-Jun;112(5-6):171-4. Lijec Vjesn. 1990. PMID: 1978212 Clinical Trial. Croatian.
[New and old therapeutic options in ankylosing spondylitis--is there an indication for sulfasalazine?].
Braun J, Sieper J. Braun J, et al. Z Rheumatol. 2002 Apr;61(2):151-8. doi: 10.1007/s003930200023. Z Rheumatol. 2002. PMID: 12056292 Review. German. No abstract available.
Sulphasalazine in ankylosing spondylitis.
Feltelius N, Hällgren R. Feltelius N, et al. Ann Rheum Dis. 1986 May;45(5):396-9. doi: 10.1136/ard.45.5.396. Ann Rheum Dis. 1986. PMID: 2872857 Free PMC article. Clinical Trial.
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: comment on the article by Clegg et al.
Helliwell PS. Helliwell PS. Arthritis Rheum. 1997 Oct;40(10):1911-2. doi: 10.1002/art.1780401035. Arthritis Rheum. 1997. PMID: 9336437 No abstract available.
Treatment of the seronegative spondyloarthropathies with sulfasalazine.
Zwillich SH, Comer SS, Lee E, Erdman WA, Lipsky PE. Zwillich SH, et al. J Rheumatol Suppl. 1988 Sep;16:33-9. J Rheumatol Suppl. 1988. PMID: 2903925 Review.

See all similar articles

Cited by

Ankylosing spondylitis. Current drug treatment.
Gran JT, Husby G. Gran JT, et al. Drugs. 1992 Oct;44(4):585-603. doi: 10.2165/00003495-199244040-00006. Drugs. 1992. PMID: 1281074
Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer.
Yang L, WenTao T, ZhiYuan Z, Qi L, YuXiang L, Peng Z, Ke L, XiaoNa J, YuZhi P, MeiLing J, QingYang F, GuoDong H, YueXiang W, JianMin X. Yang L, et al. Oncogene. 2022 Jun;41(23):3210-3221. doi: 10.1038/s41388-022-02284-z. Epub 2022 May 3. Oncogene. 2022. PMID: 35505093
Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication?
Ward MM. Ward MM. Arthritis Rheum. 2011 Jun;63(6):1472-4. doi: 10.1002/art.30225. Arthritis Rheum. 2011. PMID: 21630241 Free PMC article. No abstract available.
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
Dougados M, Boumier P, Amor B. Dougados M, et al. Br Med J (Clin Res Ed). 1986 Oct 11;293(6552):911-4. doi: 10.1136/bmj.293.6552.911. Br Med J (Clin Res Ed). 1986. PMID: 2876744 Free PMC article. Clinical Trial.
Evaluation of sulphasalazine in the treatment of spondyloarthropathies.
Dougados M, Maetzel A, Mijiyawa M, Amor B. Dougados M, et al. Ann Rheum Dis. 1992 Aug;51(8):955-8. doi: 10.1136/ard.51.8.955. Ann Rheum Dis. 1992. PMID: 1358038 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program